Accomplished Individuals with a Mission
Bill joined Vigilant Biosciences in the summer of 2018 as CEO to lead the Company’s transition from a development organization to a successful commercial enterprise. Bill brings over 20 years of experience in management roles. Previously, he served as Chief Commercial Officer of Vital Connect, a leader in wearable biosensor technology for wireless hospital and remote patient monitoring. He earlier served as Global Vice President of Sales and Marketing at myoscience where he built and led all commercial operations. Bill also served as Vice President of Global Sales at Solta Medical. From 1998 to 2006, Bill served as Vice President of Sales and Field Operations and held various sales management positions with Benco Dental, a $400M company specializing in dental office equipment sales, office design and supply management. His expertise includes team leadership, sales management and international business management.
Bill earned a Master of Science in Management from Georgia Institute of Technology and a Bachelor of Science in Mathematics from Rollins College.
Mr. Barabe brings to Vigilant Biosciences Board and C-level experience across a variety of different life science companies. Since 2001, Mr. Barabe has been on the Board of Directors of Opexa Therapeutics, a biotechnology company based in The Woodlands, Texas since March 2014.
Mr. Barabe retired in June 2013 from his position as Executive Vice President and Chief Financial Officer of Affymetrix, Inc. Previously, from July 2006 until March 2010, he was Senior Vice President and Chief Financial Officer of Human Genome Sciences, Inc. He was with Regent Medical Limited, a U.K.-based, privately owned, surgical supply company, where he was Chief Financial Officer, from 2004 to 2006. Mr. Barabe served with Novartis AG from 1982 through August 2004 in a succession of senior executive positions in finance and general management, most recently as the Chief Financial Officer of Sandoz GmbH, the generic pharmaceutical subsidiary of Novartis. Mr. Barabe received his B.B.A. degree from the University of Massachusetts (Amherst) and his M.B.A. degree from the University of Chicago.
Dr. Linda Niessen is a Dean and Professor at the Nova Southeastern University College of Dental Medicine in Fort Lauderdale, Florida, the only dental school in South Florida and the first private dental school in Florida.
Prior to this position, she served as a professor at Baylor College of Dentistry, Texas A&M University in Dallas from 1991 to 2013. In addition to her academic career, Dr. Niessen held executive positions at DENTSPLY International, a leading manufacturer and distributor of dental and other consumable medical device products, including most recently as Vice President, Chief Clinical Officer and prior as DENTSPLY’s Vice President, Clinical Education.
Dr. Niessen received her B.A. degree from the University of New Mexico and her D.M.D. degree from the Harvard School of Dental Medicine. Additionally, she received a M.P.H. degree from Harvard School of Public Health, a Certificate in Dental Public Health from Harvard School of Dental Medicine and a M.P.P. degree from the John F. Kennedy School of Government, Harvard University.
Mr. Treadway earned his Bachelor and Master of Science degrees in electrical engineering from the University of Louisiana-Lafayette and Clemson University, respectively, and a M.B.A. from Harvard Business School.
Elizabeth Franzmann, M.D. is Vigilant Biosciences’ Scientific Founder & Scientific Advisor. Her innovative clinical research on selective salivary biomarkers for head and neck squamous cell carcinoma serves as the foundation for Vigilant Biosciences’ product line. Dr. Franzmann is certified by the American Board of Otolaryngology and a Fellow of the American College of Surgeons. She is a Professor of Otolaryngology at the University of Miami, Miller School of Medicine specializing in head and neck surgery. She has been recognized as one of the “Best Doctors in America”. Over the past decade, she has worked in close partnership with Vigilant Biosciences, translating bench research into solutions that address unmet patient needs. Her work has been funded by foundations, state and federal agencies with numerous resulting patents and publications in well-respected, and peer-reviewed journals.
Dr. Franzmann earned a Bachelor of Science and Doctorate of Medicine at the University of California, Los Angeles.